Anhui Fengyuan Pharmaceutical Co., Ltd.

000153

CNE0000014X5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
8.33 ^CNY	+1.83%		+12.26%	-11.10%

Apr. 26	Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	CI
Apr. 25	Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Anhui Fengyuan Pharmaceutical Announces Cash Dividend for 2022

May 19, 2023 at 03:42 pm EDT

Anhui Fengyuan Pharmaceutical Co., Ltd. announced final cash dividend (tax included) for 2022 of CNY 1.00000000 per 10 shares at AGM held on May 18, 2023.

Latest news about Anhui Fengyuan Pharmaceutical Co., Ltd.

Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	Apr. 26	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. canceled the acquisition of Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.	23-06-19	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 16, 2023	23-06-09	CI
Anhui Fengyuan Pharmaceutical Announces Cash Dividend for 2022	23-05-19	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend (Tax Included) for 2022	23-04-20	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. agreed to acquire Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.	23-04-07	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. announced a financing transaction	23-01-02	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. signed an equity transfer agreement to acquire Anhui Fengyuan Gelatin Co., Ltd. from BBCA Group Co., Ltd. for approximately CNY 308 million.	22-10-11	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Management Appointments	22-07-08	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 05 July 2022	22-06-29	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Distribution for 2021	22-05-26	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021	22-04-29	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-22	CI
Xiamen jindawei Group Co signed the equity transfer agreement to acquire 28.41% stake in Jiangsu Chengxin Pharmaceutical Co Ltd from Anhui Fengyuan Pharmaceutical Co., Ltd. for CNY 100 million.	20-12-01	CI

Chart Anhui Fengyuan Pharmaceutical Co., Ltd.

Duration

Period

Chart Anhui Fengyuan Pharmaceutical Co., Ltd.

More charts

ANHUI FENGYUAN PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, manufacture and distribution of biological medicines, chemical synthetic medicines and Chinese medicines. The Company's products mainly include antipyretic and analgesic, women and children, the nervous system, cardiovascular, urinary system, nutrition, antibiotics and active ingredient and other products. The Company is also engaged in the retailing and wholesale of drugs. The Company conducts its businesses mainly in domestic markets, with Anhui province as its main market.

Sector

Pharmaceuticals

Calendar

2024-05-22 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD.	-11.10%	375M
ELI LILLY AND COMPANY	+26.47%	661B
NOVO NORDISK A/S	+26.74%	566B
JOHNSON & JOHNSON	-6.33%	352B
MERCK & CO., INC.	+19.35%	332B
ABBVIE INC.	+4.23%	283B
ASTRAZENECA PLC	+13.43%	231B
NOVARTIS AG	+4.71%	200B
ROCHE HOLDING AG	-9.53%	195B
AMGEN INC.	-4.04%	145B